| 降纤酶联合规范方案治疗非ST段抬高心肌梗死的疗效观察 |
| 投稿时间：2013-05-11 修订日期：2013-11-03 点此下载全文 |
| 引用本文：赵让,刘欣.降纤酶联合规范方案治疗非ST段抬高心肌梗死的疗效观察[J].药学实践杂志,2014,32(2):118~120 |
| 摘要点击次数: 1220 |
| 全文下载次数: 86 |
|
|
| 中文摘要:目的 探讨应用降纤酶治疗非ST段抬高心肌梗死的临床疗效及其对预后的影响。方法 选取住院非ST段抬高心肌梗死患者86例,随机分为对照组和治疗组,均给予规范化方案治疗,而治疗组在此基础上加用降纤酶。结果 治疗组临床有效率明显高于对照组;心肌酶、高敏C反应蛋白水平明显低于对照组(P<0.05)。结论 在规范治疗的基础上加用降纤酶更有利于改善患者的临床症状、减少并发症的发生,并对心肌梗死后心肌重构有一定抑制作用。 |
| 中文关键词:降纤酶 急性非ST段抬高心肌梗死 hs-CR |
| |
| Efficacy observation of defibrase combined standard regimen in treatment of non ST segment elevation myocardial infarction |
|
|
| Abstract:Objective To discuss the effectiveness of defibrase in the treatment of NSTEMI and effects of defibrase on the prognosis of NSTEMI. Methods 86 patients with NSTEMI were randomly divided into treatment group and control group, patients received standard treatment, and treatment group added defibrase. Results The effective rates of the treatment group was significantly higher than control group, the level of myocardial enzymes and hs-CRP was significantly lower than control group(P<0.05). Conclusion Based on standard treatment with defibrase was more conducive to improve clinical symptoms, reduce complications, and there were some inhibitory effect on the development of myocardial remodeling after myocardial infarction. |
| keywords:defibrase NSTEMI hs-CR |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
